Hampton Creek Press (print and distribution provided by Simon & Schuster) Announces Behind a Closed Door, the Latest Novel by Writer J.D. Barker
April 17, 2024 13:51 ET | Hampton Creek Press
The long-awaited thriller from New York Times bestselling author J.D. Barker is available for preorder now and will be released on May 13, 2024.
IMF_logo_RGB.png
International Myeloma Foundation and the Black Swan Research Initiative Showcase Six Oral & Poster Abstracts by the iStopMM Project at the 2023 ASH Annual Meeting
January 12, 2024 08:45 ET | International Myeloma Foundation
International Myeloma Foundation and the Black Swan Research Initiative Showcase Six Oral & Poster Abstracts by the iStopMM Project at ASH 2023
Picture1.png
Autolus Therapeutics Presents Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2023
December 09, 2023 20:30 ET | Autolus Therapeutics plc
Autolus Therapeutics Presents Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2023
Agios_2021_Logo.png
Agios Presents Positive Results from Phase 2 Portion of the RISE UP Pivotal Study in Sickle Cell Disease at 65th ASH Annual Meeting and Exposition
December 09, 2023 19:00 ET | Agios Pharmaceuticals, Inc.
Agios Presents Positive Results from Phase 2 Portion of the RISE UP Pivotal Study in Sickle Cell Disease at 65th ASH Annual Meeting and Exposition
Aptose Biosciences Inc. logo
Aptose Tuspetinib Clinical Data Featured in Oral Presentation at the 2023 ASH Annual Meeting
December 09, 2023 18:30 ET | Aptose Biosciences, Inc.
ASH Oral Presentation: Complete Response Data from the Ongoing APTIVATE Phase 1/2 Study of Tuspetinib (TUS) in R/R AML Patients
Cellectis Logo.png
Cellectis to Present Preliminary Results of NATHALI_01 and Updated Results of the BALLI_01 Phases I Trials at the American Society of Hematology (ASH) 65th Annual Meeting
November 02, 2023 16:30 ET | Cellectis Inc.
NEW YORK, Nov. 02, 2023 (GLOBE NEWSWIRE) --  Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to...
Novalgen_logo_on_white.jpg
NovalGen announces one oral and one poster presentation at the 65th American Society of Hematology Annual Meeting
November 02, 2023 15:18 ET | NovalGen Ltd.
NovalGen announces one oral and one poster presentation at the 65th American Society of Hematology Annual Meeting
TIP_link_300x300.jpg
Fly Ash Market to Reach $45.73Bn by 2028 at 4.8% CAGR with Type C Fly Ash Segment Driving Growth During 2021–2028 | The Insight Partners
July 05, 2023 07:55 ET | The Insight Partners
Pune, India, July 05, 2023 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Fly Ash Market Size Report, Share, Growth Strategy, Industry Trends, and Forecast to 2028-...
truth.courage.love.
Author, Speaker, and Life Coach Terry Sidford Releases Second Book: truth.courage.love.
February 01, 2023 10:30 ET | Terry Sidford, author
PARK CITY, Utah, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Terry Sidford, a seasoned author, motivational speaker, and life coach has published her second book: truth.courage.love. Inspired by her once...
Studies with FCS Participation Highlighted at the 2022 San Antonio Breast Cancer Symposium
Florida Cancer Specialists & Research Institute Contributing to Rapid Advancements in Breast Cancer Treatment
December 13, 2022 13:58 ET | Florida Cancer Specialists & Research Institute
Fort Myers, Florida, Dec. 13, 2022 (GLOBE NEWSWIRE) -- Florida Cancer Specialists & Research Institute, LLC (FCS) hematologists and medical oncologists were contributors to several presentations...